Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria M Richon

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Epigenomics|November 30, 2011
Targeting histone deacetylases: development of vorinostat for the treatment of cancerVictoria M Richon
Nature Biotechnology|June 10, 2008
A new path to the cancer epigenomeVictoria M Richon
Hematology. American Society of Hematology. Education Program|December 10, 2013
Drug discovery in rare indications: opportunities and challengesVictoria M Richon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatmentVictoria M Richon, James P O'Brien
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implicationsValeria R Fantin, Victoria M Richon
Current Opinion in Pharmacology|August 7, 2003
Histone deacetylasesPaul A Marks, Thomas Miller, Victoria M Richon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Vorinostat-Gateway to Epigenetic TherapyWm Kevin Kelly, Paul Marks, Victoria M Richon
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
HDAC inhibitors for the treatment of cancerJ Paul Secrist, Xianbo Zhou, Victoria M Richon
Cancer Letters|February 3, 2009
Development of vorinostat: current applications and future perspectives for cancer therapyVictoria M Richon, Jose Garcia-Vargas, James S Hardwick
Nature Reviews. Drug Discovery|September 2, 2009
Protein methyltransferases as a target class for drug discoveryRobert A Copeland, Michael E Solomon, Victoria M Richon
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Epigenomics|November 30, 2011
Targeting histone deacetylases: development of vorinostat for the treatment of cancerVictoria M Richon
Nature Biotechnology|June 10, 2008
A new path to the cancer epigenomeVictoria M Richon
Hematology. American Society of Hematology. Education Program|December 10, 2013
Drug discovery in rare indications: opportunities and challengesVictoria M Richon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatmentVictoria M Richon, James P O'Brien
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implicationsValeria R Fantin, Victoria M Richon
Current Opinion in Pharmacology|August 7, 2003
Histone deacetylasesPaul A Marks, Thomas Miller, Victoria M Richon
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Vorinostat-Gateway to Epigenetic TherapyWm Kevin Kelly, Paul Marks, Victoria M Richon
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
HDAC inhibitors for the treatment of cancerJ Paul Secrist, Xianbo Zhou, Victoria M Richon
Cancer Letters|February 3, 2009
Development of vorinostat: current applications and future perspectives for cancer therapyVictoria M Richon, Jose Garcia-Vargas, James S Hardwick
Nature Reviews. Drug Discovery|September 2, 2009
Protein methyltransferases as a target class for drug discoveryRobert A Copeland, Michael E Solomon, Victoria M Richon
Pageof 6